Sacubitril/valsartan is contraindicated in patients with:

- Hypersensitivity to any component of the product

- A prior history of angioedema due to an ACEI or ARB

- In diabetic patients receiving the renin inhibitor, aliskiren, specifically, the valsartan (any ARB), is contraindicated with aliskiren due to an increased risk of hypotension, hyperkalemia, and renal impairment.

- Patients who have received an ACE-inhibitors within 36 hours due to increased risk of angioedema.

**Box Warning**

- Drugs that work directly on the renin-angiotensin system, such as sacubitril/valsartan, can cause injury and/or death to the developing fetus. When pregnancy is confirmed, discontinue sacubitril/valsartan as soon as possible.